A Study of Tazemetostat in Combination With Various Treatments in Participants With Blood Cancer.

Clinical trial NCT05205252 · WITHDRAWN

Trial details

NCT number: NCT05205252
Sponsor: Epizyme, Inc.
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsed Hematologic Malignancy Refractory Hematologic Malignancy

Start date: 2021-12-22
Primary completion: 2023-07-05
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.